Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Chongqing Zhifei Biological Products Co Ltd
Cash from Investing Activities
Chongqing Zhifei Biological Products Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥993.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥2.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Investing Activities
-¥36.1m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-993.8m
CNY
Based on the financial report for Sep 30, 2023, Chongqing Zhifei Biological Products Co Ltd's Cash from Investing Activities amounts to -993.8m CNY.
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-14%
Over the last year, the Cash from Investing Activities growth was 36%. The average annual Cash from Investing Activities growth rates for Chongqing Zhifei Biological Products Co Ltd have been -10% over the past three years , -18% over the past five years , and -14% over the past ten years .